A Multi-center, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Generic Entecavir Monotherapy or in Combination With Adefovir for Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Jun 2014
At a glance
- Drugs Entecavir (Primary) ; Adefovir dipivoxil
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms Dragon
- 29 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Mar 2012 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 29 Apr 2011 New trial record